BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21224835)

  • 61. Clinical features of autosomal dominant retinitis pigmentosa with rhodopsin gene codon 17 mutation and retinal neovascularization in a Japanese patient.
    Hayakawa M; Hotta Y; Imai Y; Fujiki K; Nakamura A; Yanashima K; Kanai A
    Am J Ophthalmol; 1993 Feb; 115(2):168-73. PubMed ID: 7679248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ocular findings associated with a rhodopsin gene codon 58 transversion mutation in autosomal dominant retinitis pigmentosa.
    Fishman GA; Stone EM; Gilbert LD; Kenna P; Sheffield VC
    Arch Ophthalmol; 1991 Oct; 109(10):1387-93. PubMed ID: 1929926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery.
    Gorbatyuk M; Justilien V; Liu J; Hauswirth WW; Lewin AS
    Vision Res; 2007 Apr; 47(9):1202-8. PubMed ID: 17292939
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of vitamin A supplementation on rhodopsin mutants threonine-17 --> methionine and proline-347 --> serine in transgenic mice and in cell cultures.
    Li T; Sandberg MA; Pawlyk BS; Rosner B; Hayes KC; Dryja TP; Berson EL
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11933-8. PubMed ID: 9751768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
    Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147
    [No Abstract]   [Full Text] [Related]  

  • 66. Autosomal dominant retinitis pigmentosa in a large family: a clinical and molecular genetic study.
    Rosas DJ; Roman AJ; Weissbrod P; Macke JP; Nathans J
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3134-44. PubMed ID: 8045708
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Homozygous and heterozygous gly-188-Arg mutation of the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa.
    Reig CM; Trujillo JM; Martinez-Gimeno MM; Garcia-Sandoval BM; Calvo TM; Ayuso C; Carballo M
    Ophthalmic Genet; 2000 Jun; 21(2):79-87. PubMed ID: 10916182
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy.
    Ali RR; Sarra GM; Stephens C; Alwis MD; Bainbridge JW; Munro PM; Fauser S; Reichel MB; Kinnon C; Hunt DM; Bhattacharya SS; Thrasher AJ
    Nat Genet; 2000 Jul; 25(3):306-10. PubMed ID: 10888879
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Identification of Arg-135-Leu mutation in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa].
    Reig C; Antich J; Gean E; Dante Heredia C; Valverde D; Baiget M; Carballo M
    Med Clin (Barc); 1996 Feb; 106(6):219-21. PubMed ID: 8667664
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment.
    Sung CH; Makino C; Baylor D; Nathans J
    J Neurosci; 1994 Oct; 14(10):5818-33. PubMed ID: 7523628
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference.
    Cashman SM; Binkley EA; Kumar-Singh R
    Gene Ther; 2005 Aug; 12(15):1223-8. PubMed ID: 15877050
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phenotypic characterization of P23H and S334ter rhodopsin transgenic rat models of inherited retinal degeneration.
    LaVail MM; Nishikawa S; Steinberg RH; Naash MI; Duncan JL; Trautmann N; Matthes MT; Yasumura D; Lau-Villacorta C; Chen J; Peterson WM; Yang H; Flannery JG
    Exp Eye Res; 2018 Feb; 167():56-90. PubMed ID: 29122605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ocular findings in patients with autosomal dominant retinitis pigmentosa and Cys110Phe, Arg135Gly, and Gln344stop mutations of rhodopsin.
    Kremmer S; Eckstein A; Gal A; Apfelstedt-Sylla E; Wedemann H; Rüther K; Zrenner E
    Graefes Arch Clin Exp Ophthalmol; 1997 Sep; 235(9):575-83. PubMed ID: 9342608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Span poly-L-arginine nanoparticles are efficient non-viral vectors for PRPF31 gene delivery: An approach of gene therapy to treat retinitis pigmentosa.
    Pensado A; Diaz-Corrales FJ; De la Cerda B; Valdés-Sánchez L; Del Boz AA; Rodriguez-Martinez D; García-Delgado AB; Seijo B; Bhattacharya SS; Sanchez A
    Nanomedicine; 2016 Nov; 12(8):2251-2260. PubMed ID: 27381066
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
    Michalakis S; Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Schulze E; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Mühlfriedel R; Biel M
    Adv Exp Med Biol; 2014; 801():733-9. PubMed ID: 24664765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis Pigmentosa.
    Massengill MT; Young B; Patel D; Jafri F; Sabogal E; Ash N; Li H; Ildefonso CJ; Lewin AS
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5417-5430. PubMed ID: 30452595
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine.
    Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Dryja TP
    Am J Ophthalmol; 1991 May; 111(5):614-23. PubMed ID: 2021172
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation.
    Lines MA; Hébert M; McTaggart KE; Flynn SJ; Tennant MT; MacDonald IM
    Ophthalmology; 2002 Oct; 109(10):1862-70. PubMed ID: 12359607
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15.
    Botta S; de Prisco N; Marrocco E; Renda M; Sofia M; Curion F; Bacci ML; Ventrella D; Wilson C; Gesualdo C; Rossi S; Simonelli F; Surace EM
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.